Insights Citeline
Published November 17, 2026
Uniquity's Phase II Solrikitug Data In EoE Rival Amgen/AstraZeneca's Tezspire
Read the full story at Insights Citeline
The company unveiled positive data from a Phase III study of HLP003, which has potential to be among the first psychedelics to win FDA approval.
Surfaced by this Google Alert
- Psychedelics asia